Oxford Asset Management’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-797,440
| Closed | -$22.8M | – | 2204 |
|
|
2018
Q4 | $22.8M | Hold |
797,440
| – | – | 0.59% | 10 |
|
|
2018
Q3 | $22.2M | Hold |
797,440
| – | – | 0.46% | 13 |
|
|
2018
Q2 | $22.2M | Hold |
797,440
| – | – | 0.43% | 19 |
|
|
2018
Q1 | $19.8M | Hold |
797,440
| – | – | 0.42% | 20 |
|
|
2017
Q4 | $19.3M | Hold |
797,440
| – | – | 0.42% | 16 |
|
|
2017
Q3 | $22M | Buy |
797,440
+732,905
| +1,136% | +$19.5M | 0.42% | 20 |
|
|
2017
Q2 | $1.62M | Sell |
64,535
-12,127
| -16% | -$300K | 0.03% | 709 |
|
|
2017
Q1 | $2.06M | Sell |
76,662
-5,458
| -7% | -$151K | 0.05% | 467 |
|
|
2016
Q4 | $2.15M | Buy |
82,120
+10,242
| +14% | +$253K | 0.08% | 309 |
|
|
2016
Q3 | $1.8M | Buy |
+71,878
| New | +$1.68M | 0.06% | 421 |
|
|
2016
Q1 | – | Sell |
-116,163
| Closed | -$2.54M | – | 974 |
|
|
2015
Q4 | $2.54M | Sell |
116,163
-57,848
| -33% | -$1.08M | 0.06% | 347 |
|
|
2015
Q3 | $2.74M | Buy |
+174,011
| New | +$2.79M | 0.09% | 242 |
|
|
2014
Q2 | – | Sell |
-261,976
| Closed | -$3.34M | – | 828 |
|
|
2014
Q1 | $3.34M | Buy |
+261,976
| New | +$3.42M | 0.1% | 281 |
|
Other funds holding NXTM
Oxford Asset Management's NXTM Position: Q1 2019 in Review
Oxford Asset Management sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 797,440 shares — an estimated $22.8M sold.
Oxford Asset Management first reported a position in NXTM in Q1 2014 and held it in 13 quarters. The position peaked at $22.8M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- Oxford Asset Management reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- Oxford Asset Management sold 797,440 NxStage Medical Inc. shares in Q1 2019, an estimated $22.8M.
- Oxford Asset Management first reported a position in NxStage Medical Inc. in Q1 2014 and held it in 13 quarters.
- Oxford Asset Management's NxStage Medical Inc. position peaked at $22.8M in Q4 2018.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on Oxford Asset Management's 13F filing for Q1 2019, filed 15 May 2019.